- General Dermatology
- Eczema
- Alopecia
- Aesthetics
- Vitiligo
- COVID-19
- Actinic Keratosis
- Precision Medicine and Biologics
- Rare Disease
- Wound Care
- Rosacea
- Psoriasis
- Psoriatic Arthritis
- Atopic Dermatitis
- Melasma
- NP and PA
- Skin Cancer
- Hidradenitis Suppurativa
- Drug Watch
- Pigmentary Disorders
- Acne
- Pediatric Dermatology
- Practice Management
GEP in Melanoma Detection with Darrell S. Rigel, MD, MS
In a video onsite at Fall Clinical Dermatology Conference, Darrell S. Rigel, MD, MS, highlights, in his own words, the potential of GEP as an adjunct to biopsy in melanoma detection.
Dermatology Times® sat down with Darrell S. Rigel, MD, MS, a clinical professor and director of the Melanoma Surveillance Clinic at the Mount Sinai Icahn School of Medicine, New York, New York, to discuss the accuracy of genetic expression profiling (GEP) in detection and diagnosis of melanoma at the Fall Clinical Dermatology Conference 2021, held October 21 to 24 in Las Vegas, Nevada, and virtual.
In the video, he highlighted the potential to use GEP to avoid unnecessary biopsies and adjunctly aid in other diagnostic procedures.
Reference:
Rigel, D. Apply GEP to melanoma detection. Presented at: Fall Clinical Dermatology Conference 2021; October 21-24, 2021; Las Vegas, Nevada and virtual.
